About this event

  • Date and time Mon 20 Jun 2022 from 9:00am to 5:50pm
  • Location Online
  • Organised by Oncology, Respiratory Medicine

Jointly organised by the Oncology and Respiratory Medicine Section, this event aims to discuss the current management of lung cancer and review the advances in diagnosis, assessment and staging.

Lung cancer diagnosis and treatment represents a rapidly changing clinical field with developments in multiple different areas. 

Our internationally renowned multidisciplinary faculty will present the current state of the art advances and treatment paradigms from early-stage lung cancer to its advanced disease.

Attendees will be able to:

  • Understand current diagnostic and staging tests for lung cancers
  • Be able to make appropriate decisions in the management of the full range and stages of lung cancer
  • Appreciate recent changes in practice and controversial areas in lung cancer management

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

We would like to thank our sponsors Amgen and GSK for their support of this meeting. Please note that the scientific programme and content has not been influenced in any way by the sponsors.

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

 

Agenda

View the programme

Welcome and introduction

Dr Michael Beckles, Consultant Respiratory and General Physician, Royal Free London NHS Foundation Trust and  Professor Christopher Nutting, President, Oncology Section, Royal Society of Medicine

Session 1: Diagnosis pathology and imaging

Dr Michael Beckles

Lung cancer in the UK – challenges to be faced

Professor Mary O’Brien, Consultant Medical Oncologist, Head of the Lung Unit, The Royal Marsden NHS Foundation Trust

Advances in pathological assessment of non-small cell lung cancer – what represents a full evaluation?

Professor Andrew Nicholson, Consultant Histopathologist, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust and Honorary Professor of Respiratory Pathology, National Heart and Lung Institute, Imperial College London

Lung cancer early diagnosis and screening

Professor David Baldwin, Consultant Respiratory Physician and Honorary Professor of Medicine, University of Nottingham

Panel discussion
Comfort break

Session 2: Intervention and surgery

Dr Michael Beckles

Advances in the diagnosis and treatment of lung cancer – what does the future hold?

Dr Justin Garner, Consultant Respiratory Physician in Lung Cancer and Interventional Bronchoscopy, Royal Brompton Hospital

Surgical talk – fitness assessment, guidelines and radical surgery

Mr Alan Kirk, Consultant Thoracic Surgeon, Golden Jubilee National Hospital

The role of systemic therapy in the perioperative period

Dr Riyaz Shah, Consultant Medical Oncologist, Maidstone and Tunbridge Wells NHS Trust

Panel discussion
Lunch

Session 3: Radiotherapy and ablation techniques

Professor Christopher Nutting

Advances in radiation oncology and chemoradiotherapy for locally advanced lung cancer

Professor Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology, University of Manchester and The Christie NHS Foundation Trust

Stereotactic body radiotherapy for localised lung cancer and metastatic disease

Professor Eric Deutsch, Head of Department, Radiotherapy Department and Indre-et-Loire Medical Unit, Gustave Roussy

Proton beam therapy and its potential role in management of lung cancer

Dr Crispin Hiley, Consultant Clinical Oncologist, University College London Hospitals NHS Foundation Trust

Panel discussion
Comfort break
Personalised therapy for mutation driven non-small cell lung cancer

Professor Sanjay Popat, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust

Advances in systemic therapy for mutation negative lung cancer

Dr Thomas Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster Hospital

Advances in management of mesothelioma

Professor Dean Fennell, Professor and Consultant in Thoracic Medical Oncology, University of Leicester

Panel discussion

Session four: Sylvia Lawler prize presentations

A fast-track surgery programme leads to timelier treatment and higher resection rates in pancreatic and peri-ampullary cancer

Harry Spiers

Real-world experience of rucaparib in patients with advanced ovarian cancer: A multi-centre United Kingdom study

Mark Lythgoe

The anisotropic component of the diffusion tensor as a prognosticator in glioblastoma

Natalie Simon

A CT-radiomics machine learning model to predict recurrence post curative-intent radiotherapy for stage I-III non small cell lung cancer (NSCLC)

Sumeet Hindocha

IR-induced damage influence on IWS1 control of G1

Emily Monts

MiR-1271-5p: An AR modulatory microRNA with a distinct role in prostate cancer progression and therapy

Foteini Kalofonou

Award of prize
End of meeting

Sponsors

Amgen logo GSK

Location

Online

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.  

Disclaimer:

  • The agenda is subject to change at any time
  • If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
  • All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
  • This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member